Literature DB >> 7534860

Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties.

V S Trubetskoy1, J A Cannillo, A Milshtein, G L Wolf, V P Torchilin.   

Abstract

Surface modification of liposomes containing Gd-diethylenetriaminepentaacetyl-phosphatidylethanolamine (Gd-DTPA-PE) as an amphiphilic paramagnetic label influences their contrast properties as MRI agents. Liposomes with the mean diameter ca. 220 nm and 10% mol content of Gd-DTPA-PE were modified with dextran (molecular weight 6 kDa) or polyethyleneglycol (PEG, molecular weight 5 kDa). The preparations obtained were used for MR visualization of axillary and subscapular lymph nodes after SC injection into rabbit's paw. Dextran-modified liposomes were found to have limited or no effect on lymph node/muscle MR signal intensity ratio during the first 2 h after the administration when compared to nonmodified plain liposomes, whereas the liposomes modified with PEG demonstrated a 3-3.5-fold enhancement of lymph node signal. However, the partial biodistribution studies with the 111In-labeled liposomes revealed that PEG-modified vesicles accumulated in the axillary lymph node at half the amount comparing with nonmodified and dextran-modified liposomes. The phenomenon found might be explained by noticeably increased relaxivity of PEG-modified Gd-liposomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534860     DOI: 10.1016/0730-725x(94)00083-f

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  15 in total

Review 1.  Imaging and drug delivery using theranostic nanoparticles.

Authors:  Siti M Janib; Ara S Moses; J Andrew MacKay
Journal:  Adv Drug Deliv Rev       Date:  2010-08-13       Impact factor: 15.470

Review 2.  Preclinical lymphatic imaging.

Authors:  Fan Zhang; Gang Niu; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

Review 3.  Functional magnetic nanoparticles for non-viral gene delivery and MR imaging.

Authors:  Ruijun Xing; Gang Liu; Jinghan Zhu; Yanglong Hou; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

Review 4.  Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

Authors:  Yumei Xie; Taryn R Bagby; M S Cohen; M Laird Forrest
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

Review 5.  Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

Authors:  Shuang Cai; Qiuhong Yang; Taryn R Bagby; M Laird Forrest
Journal:  Adv Drug Deliv Rev       Date:  2011-06-25       Impact factor: 15.470

6.  Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents.

Authors:  Zhiliang Cheng; Daniel L J Thorek; Andrew Tsourkas
Journal:  Adv Funct Mater       Date:  2009-12-09       Impact factor: 18.808

7.  Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle.

Authors:  Daniel L J Thorek; David Ulmert; Ndeye-Fatou M Diop; Mihaela E Lupu; Michael G Doran; Ruimin Huang; Diane S Abou; Steven M Larson; Jan Grimm
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

Review 8.  Contrast-enhanced MR imaging of lymph nodes in cancer patients.

Authors:  Seung Hong Choi; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

9.  Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging.

Authors:  Tot Bui; Jeff Stevenson; John Hoekman; Shanrong Zhang; Kenneth Maravilla; Rodney J Y Ho
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

Review 10.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.